At a glance
- Originator Kyowa Hakko
- Class Glucosides; Neuroprotectants; Nootropics; Small molecules; Terpenes
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cognition disorders
Most Recent Events
- 26 May 2001 No-Development-Reported for Cognition disorders in Japan (Unknown route)
- 04 Dec 1996 Preclinical development for Cognition disorders in Japan (Unknown route)